SCHEMBL7415008

SCHEMBL7415008

N=C(N)NOCCCOc1ccc(C[C@H](NS(=O)(=O)c2cccc(Cl)c2)C(=O)OC(=O)C(F)(F)F)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
F2 P00734 7/20 0.42
TMPRSS6 Q8IU80 6/20 0.42
ITGB3 P05106 8/20 0.40
ITGA2B P08514 8/20 0.40
ITGAV P06756 6/20 0.40
CTSL P07711 2/20 0.39
CTSB P07858 2/20 0.39
CTSS P25774 2/20 0.39
CTSK P43235 2/20 0.39
F10 P00742 1/20 0.38
PLG P00747 1/20 0.38
PLAU P00749 1/20 0.38
ST14 Q9Y5Y6 1/20 0.38
ITGB1 P05556 1/20 0.37
ITGA5 P08648 1/20 0.37
FFAR1 O14842 1/20 0.36
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7416602 0.93 ITGB3 (0.38) F2TMPRSS6ITGB3ITGA2BITGAV
SCHEMBL7415682 0.91 TMPRSS6 (0.43) F2TMPRSS6ITGB3ITGA2BITGAV
SCHEMBL7419584 0.91 F2 (0.42) F2TMPRSS6ITGB3ITGA2BITGAV
SCHEMBL7415996 0.91 F2 (0.42) F2TMPRSS6ITGB3ITGA2BITGAV
SCHEMBL7414434 0.90 F2 (0.42) F2TMPRSS6ITGB3ITGA2B
SCHEMBL7417592 0.90 ITGB3 (0.49) F2TMPRSS6ITGB3ITGA2BITGAV
SCHEMBL7415413 0.90 TMPRSS6 (0.38) F2TMPRSS6ITGB3ITGA2BITGAV
Trifluoroacetic Acid SCHEMBL7415002 0.90 ITGB3 (0.49) F2TMPRSS6ITGB3ITGA2BITGAV
SCHEMBL7412728 0.89 F2 (0.39) F2TMPRSS6ITGB3ITGA2BITGAV
SCHEMBL7417130 0.88 F2 (0.45) F2TMPRSS6ITGB3ITGA2BF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6344484-B1 TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-02-05 US disclosed
EP-1159262-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000047552-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO disclosed